MDJM Ltd received final confirmation from Nasdaq that its Class A ordinary shares will be delisted. The Nasdaq Hearings Panel initially denied reinstatement on May 14, 2026, and the Listing Council affirmed this decision on July 28, 2026. On August 12, 2026, the Nasdaq Board of Directors declined to review the appeal, making the delisting final under Nasdaq Listing Rule 5830. The company's shares are currently quoted on the OTCQB Venture Market under the ticker symbol UOKAF. MDJM Ltd operates in the digital health technology sector, providing remote patient monitoring and chronic disease management solutions.
